Efficacy of liraglutide in a patient with type 2 diabetes andcryptogenic cirrhosis

Efficacy of liraglutide in a patient with type 2 diabetes andcryptogenic cirrhosis

Authors

  • E. D'amico

Keywords:

Type 2 diabetes mellitus, cryptogenic cirrhosis, liraglutide

Abstract

In this work Author presents a case report of a female patient of 65 years old who had suffered from type 2 diabetes mellitus and from concomitant cryptogenic cirrhosis. She was treated with liraglutide, an analogue of human GLP-1, obtaining an optimal metabolic control associated with an improved clinical condition for the cirrhosis.

Downloads

Published

01-06-2011

Issue

Vol. 82 No. 2 (2011)

Section

CASE REPORTS

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
D'amico E. Efficacy of liraglutide in a patient with type 2 diabetes andcryptogenic cirrhosis. Acta Biomed. 2011;82(2):160-161. Accessed January 17, 2025. https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/1406